Swallowing therapy for dysphagia in acute and subacute stroke

医学 吞咽困难 吞咽 冲程(发动机) 急性中风 物理医学与康复 物理疗法 外科 食管 康复 疾病
作者
Gwenllian Wilkinson,Lisa F. Everton,Philip M. Bath,Jacqueline K. Benfield
出处
期刊:The Cochrane library [Elsevier BV]
卷期号:2026 (8): CD000323-CD000323
标识
DOI:10.1002/14651858.cd000323.pub4
摘要

RATIONALE: Post-stroke dysphagia ((PSD) impaired swallowing following stroke), increases risk of death, yet the effects of potential treatments are unclear. This review updates the 2018 review. OBJECTIVES: To assess the effects of swallowing therapies on swallowing impairment (SI) among stroke survivors with dysphagia, within six months of stroke onset. SEARCH METHODS: We searched MEDLINE, Embase, OVID, three other databases and trials registries on 31 July 2025. ELIGIBILITY CRITERIA: Randomised controlled trials (RCTs) that compared interventions for PSD with usual care. OUTCOMES: Critical outcome: SI. Important outcomes: dysphagia at end of trial (DET), penetration/aspiration scale (PAS) score, chest infection or pneumonia (CI/P), and decannulation. RISK OF BIAS: We assessed risk of bias using the Cochrane Risk of bias 1 tool (RoB 1). SYNTHESIS METHODS: We calculated odds ratios (ORs), mean differences (MDs) and standardised mean differences (SMDs), with 95% confidence intervals (CIs), using random-effects models. We assessed the certainty of evidence with GRADE. INCLUDED STUDIES: We included 181 trials with 11,500 participants (140 new trials (8840 participants) in this update) that compared usual care with acupuncture, behavioural interventions, drug interventions, neuromuscular electrical stimulation (NMES), pharyngeal electrical stimulation (PES), physical stimulation, theta burst stimulation (TBS), transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS), vagal nerve stimulation and combined interventions. SYNTHESIS OF RESULTS: Acupuncture may reduce SI but effects are uncertain (SMD -1.20, 95% CI -1.50 to -0.90; 37 RCTs, 3335 participants; very low-certainty evidence); probably reduces DET (OR 0.40, 95% CI 0.33 to 0.47; 36 RCTs, 3647 participants) and PAS (MD -0.90, 95% CI -1.25 to -0.56; 8 RCTs, 496 participants) (both moderate-certainty evidence); and may reduce CI/P (OR 0.47, 95% CI 0.25 to 0.85; 4 RCTs, 426 participants; low-certainty evidence). Behavioural interventions may reduce SI (SMD -1.17, 95% CI -1.60 to -0.74; 26 RCTs, 1224 participants) and DET (OR 0.41, 95% CI 0.30 to 0.57; 9 RCTs, 958 participants), and have little to no effect on decannulation (OR 0.17, 95% CI 0.01 to 3.88, 1 RCT, 22 participants), but effects are uncertain (all very low-certainty evidence); and may reduce PAS (MD -0.99, 95% CI -1.42 to -0.55; 16 RCTs, 586 participants) and CI/P (OR 0.45, 95% 0.27 to 0.76; 8 RCTs, 784 participants) (both low-certainty evidence). Drug interventions may reduce SI but effects are uncertain (SMD -0.89, 95% CI -1.62 to -0.15; 3 RCTs, 140 participants; very low-certainty evidence); may have little to no effect on DET (OR 0.48, 95% CI 0.07 to 3.35; 1 RCT, 17 participants; low-certainty evidence); and probably reduce CI/P (drug therapy: 27% versus control: 87%, OR 0.06, 95% CI 0.01 to 0.21; 1 RCT, 60 participants; moderate-certainty evidence). NMES probably reduces SI (SMD -0.69, 95% CI -1.01 to -0.37; 20 RCTs, 866 participants; moderate-certainty evidence); and may reduce DET (OR 0.43, 95% CI 0.28, 0.67; 7 RCTs, 383 participants) but not PAS (MD -0.71, 95% CI -1.75 to 0.34; 6 RCTs, 155 participants) or CI/P (OR 0.30, 95% CI 0.03 to 3.03; 4 RCTs, 189 participants) though the effects are uncertain (all very low-certainty evidence). PES may have little to no effect on SI (SMD -0.15, 95% CI -0.46 to 0.16; 5 RCTs, 272 participants), but may reduce PAS (MD -0.74, 95% CI -1.44 to -0.03; 5 RCTs, 195 participants) and CI/P (OR 0.33, 95% CI 0.12 to 0.93; 2 RCTs, 88 participants); all low-certainty evidence. PES probably has little to no effect on DET (DET: 68% control: 78%; OR 0.55, 95% CI 0.15 to 2.11; 3 RCTs, 66 participants) but probably increases decannulation (OR 0.09, 95% CI 95% CI 0.03 to 0.28; 2 RCTs, 98 participants; moderate-certainty evidence). Physical stimulation may reduce SI (SMD -0.78, 95% CI -1.29 to -0.26; 3 RCTs, 228 participants), DET (OR 0.29, 95% CI 0.14 to 0.60; 4 RCTs, 350 participants), and CI/P (OR 0.20, 95% CI 0.05 to 0.76; 1 RCT, 96 participants); all low-certainty evidence. TBS may reduce SI (SMD -0.81, 95% CI -1.06 to -0.56; 5 RCTs, 280 participants; low-certainty evidence) and PAS but effects are uncertain (MD -1.26, 95% CI -2.04 to -0.48; 5 RCTs, 280 participants; very low-certainty evidence). tDCS: probably reduces SI (SMD -0.63, 95% CI -0.81 to -0.44; 14 RCTs, 496 participants; moderate-certainty evidence), may reduce DET (OR 0.28, 95% CI 0.09 to 0.88; 3 RCTs, 118 participants; low-certainty evidence), but effects on PAS are unclear (MD -0.82, 95% CI -1.83 to 0.18; 4 RCTs, 135 participants; very low-certainty evidence). TMS: may reduce SI (SMD -1.03, 95% CI -1.38 to -0.69; 17 RCTs, 661 participants; low-certainty evidence) and likely reduces PAS (MD -1.19, 95% CI -1.53 to -0.85; 12 RCTs, 519 participants; moderate-certainty evidence). Vagus nerve stimulation probably reduces SI (SMD -1.27, 95% CI -1.97 to -0.58; 1 RCT, 39 participants; moderate-certainty evidence). Combined therapies probably reduce SI (SMD -1.45, 95% CI -2.04 to -0.85; 8 RCTs, 334 participants), but not CI/P (OR 0.08, 95% CI 0.00 to 1.47; 1 RCT, 70 participants) (both moderate-certainty evidence), and may make little to no difference to DET (OR 0.19, 95% CI 0.03 to 1.34; 2 RCTs, 65 participants; low-certainty evidence). AUTHORS' CONCLUSIONS: Conclusions from our analyses are limited by small trials at high or unclear risk of bias, publication bias and inconsistent results. Large high-quality trials on specific interventions are needed. FUNDING: No dedicated funding. REGISTRATION: Protocol (1997), DOI not available Original review (1999) DOI 10.1002/14651858.CD000323 First update (2012) DOI 10.1002/14651858.CD000323.pub2 Second update (2018) DOI 10.1002/14651858.CD000323.pub3.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
香蕉觅云的应助被哟邮票采纳,获得10
刚刚
1秒前
1秒前
1秒前
aaaa的应助被搞科研的肥宅吴采纳,获得30
1秒前
1秒前
123发布了新的文献求助10
1秒前
mvver完成签到,获得积分20
2秒前
科目三的应助被samxie采纳,获得10
2秒前
Jxh关注了科研通微信公众号
3秒前
3秒前
lkk完成签到,获得积分10
4秒前
4秒前
5秒前
6秒前
爆米花的应助被yzy采纳,获得10
6秒前
6秒前
哒哒哒哒哒哒完成签到,获得积分20
7秒前
7秒前
7秒前
Ava的应助被zhangxu采纳,获得10
8秒前
9秒前
9秒前
9秒前
10秒前
yy完成签到 ,获得积分10
10秒前
zcc完成签到 ,获得积分10
10秒前
温婉的流沙完成签到,获得积分10
10秒前
11秒前
科研通AI6.2的应助被weallaoliao采纳,获得10
12秒前
12秒前
饭团发布了新的文献求助10
12秒前
糯米丸子完成签到,获得积分10
12秒前
yy关注了科研通微信公众号
13秒前
14秒前
来来完成签到,获得积分10
14秒前
端庄的香薇完成签到,获得积分10
14秒前
15秒前
啊呦阿柚发布了新的文献求助10
15秒前
Judy1111发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153668
求助须知:如何正确求助?哪些是违规求助? 9550448
关于积分的说明 21698499
捐赠科研通 7742484
什么是DOI,文献DOI怎么找? 3425564
关于科研通互助平台的介绍 2550698
邀请新用户注册赠送积分活动 2469211